Literature DB >> 20082678

Responsiveness of generic and disease-specific health-related quality of life instruments to venous ulcer healing.

Andrew Jull1, Varsha Parag, Natalie Walker, Anthony Rodgers.   

Abstract

The aim of the study was to evaluate the responsiveness of the Short Form Health Survey, the EuroQol 5 Dimension questionnaire, and the Charing Cross Venous Ulcer Questionnaire (CXVUQ) to venous ulcer healing. Participants had health-related quality of life measured at baseline and 12 weeks. Standardized response means were calculated to assess the responsiveness of the instruments to change in an ulcer state (healed vs. unhealed). Three hundred and sixty-eight participants completed the questionnaires at baseline and 360 at 12 weeks. One hundred and ninety-three participants (54%) had healed at 12 weeks. The standardized response means ranged from -0.01 to 0.47 for Short Form Health Survey, 0.10-0.31 for EuroQol 5 Dimension questionnaire, and -0.21 to -0.92 for CXVUQ. Differences between healed and unhealed participants at 12 weeks were significantly different for three of the eight domains on Short Form Health Survey and on all domains for the CXVUQ. There were no significant differences between the groups on the EuroQol 5 Dimension questionnaire scales. CXVUQ was more responsive than the generic instruments to change in ulcer status over 12 weeks for measuring health-related quality of life of patients with venous ulceration.

Entities:  

Mesh:

Year:  2010        PMID: 20082678     DOI: 10.1111/j.1524-475X.2009.00556.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  8 in total

1.  Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Serbia.

Authors:  Mirjana Zlatkovic-Svenda; Matthew Rouse; Marija Radak-Perovic; Roksanda Stojanovic; Nada Vujasinovic-Stupar; Biljana Lazovic-Popovic; Jeanette Wilburn; Stephen P McKenna
Journal:  Rheumatol Int       Date:  2016-10-31       Impact factor: 2.631

2.  Further international adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire.

Authors:  Jeanette Wilburn; Stephen P McKenna; James Twiss; Matthew Rouse; Mariusz Korkosz; Roman Jancovic; Petr Nemec; César Francisco Pacheco-Tena; Alain Saraux; Rene Westhovens; Patrick Durez; Mona Martin; Marika Tammaru
Journal:  Rheumatol Int       Date:  2014-10-01       Impact factor: 2.631

3.  Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.

Authors:  J Twiss; S P McKenna
Journal:  Qual Life Res       Date:  2014-01-30       Impact factor: 4.147

4.  Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease.

Authors:  Rashad Carlton; Rajiv Mallick; Chelsey Campbell; Aditya Raju; Thomas O'Donnell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2015-10

Review 5.  Investigating quality of life instrument measurement properties for adults with active venous leg ulcers: A systematic review.

Authors:  Shiwen Liu; Victoria Team; Yunjing Qiu; Carolina D Weller
Journal:  Wound Repair Regen       Date:  2022-06-15       Impact factor: 3.401

6.  Quality of life profile and correlated factors in chronic leg ulcer patients in the mid-west of São Paulo State, Brazil.

Authors:  Patrick Alexander Wachholz; Paula Yoshiko Masuda; Dejair Caitano Nascimento; Cecilia Midori Higashi Taira; Norma Gondim Cleto
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

Review 7.  Systematic review assessing the measurement properties of patient-reported outcomes for venous leg ulcers.

Authors:  E Poku; A Aber; P Phillips; M Essat; H Buckley Woods; S Palfreyman; E Kaltenthaler; G Jones; J Michaels
Journal:  BJS Open       Date:  2017-11-13

8.  Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review.

Authors:  Sophie E R Horbach; Amber P M Rongen; Roy G Elbers; Chantal M A M van der Horst; Cecilia A C Prinsen; Phyllis I Spuls
Journal:  Qual Life Res       Date:  2019-09-23       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.